View in EDS

Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

Saved in:
Bibliographic Details
Title: Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
Authors: Mehta-Shah N; Washington University School of Medicine in St. Louis, Saint Louis, MO., Zinzani PL; IRCCS Azienda Ospedalierao-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Jacobsen ED; Dana-Farber Cancer Institute, Boston, MA., Zain J; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mead M; Division of Hematology/Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA.; Clinical Research Solutions, ProPharma Group, Raleigh, NC., Casulo C; University of Rochester Medical Center - James P. Wilmot Cancer Institute, Rochester, NY., Gritti G; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Pinter-Brown L; University of California-Irvine, Irvine, CA., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Sidransky D; Johns Hopkins University, Baltimore, MD., Bentur OS; Secura Bio, Inc, Berkeley Heights, NJ., Pro B; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY., Fox CP; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Brammer JE; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 May 20, pp. JCO2503120. Date of Electronic Publication: 2026 May 20.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42018969
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mehta-Shah+N%22">Mehta-Shah N</searchLink>; Washington University School of Medicine in St. Louis, Saint Louis, MO.<br /><searchLink fieldCode="AU" term="%22Zinzani+PL%22">Zinzani PL</searchLink>; IRCCS Azienda Ospedalierao-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Jacobsen+ED%22">Jacobsen ED</searchLink>; Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Zain+J%22">Zain J</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Mead+M%22">Mead M</searchLink>; Division of Hematology/Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA.; Clinical Research Solutions, ProPharma Group, Raleigh, NC.<br /><searchLink fieldCode="AU" term="%22Casulo+C%22">Casulo C</searchLink>; University of Rochester Medical Center - James P. Wilmot Cancer Institute, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Gritti+G%22">Gritti G</searchLink>; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Pinter-Brown+L%22">Pinter-Brown L</searchLink>; University of California-Irvine, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Izutsu+K%22">Izutsu K</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sidransky+D%22">Sidransky D</searchLink>; Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Bentur+OS%22">Bentur OS</searchLink>; Secura Bio, Inc, Berkeley Heights, NJ.<br /><searchLink fieldCode="AU" term="%22Pro+B%22">Pro B</searchLink>; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Fox+CP%22">Fox CP</searchLink>; School of Medicine, University of Nottingham, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brammer+JE%22">Brammer JE</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Horwitz+SM%22">Horwitz SM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2026 May 20, pp. JCO2503120. <i>Date of Electronic Publication: </i>2026 May 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42018969
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-03120
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: JCO2503120
    Titles:
      – TitleFull: Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mehta-Shah N
      – PersonEntity:
          Name:
            NameFull: Zinzani PL
      – PersonEntity:
          Name:
            NameFull: Jacobsen ED
      – PersonEntity:
          Name:
            NameFull: Zain J
      – PersonEntity:
          Name:
            NameFull: Mead M
      – PersonEntity:
          Name:
            NameFull: Casulo C
      – PersonEntity:
          Name:
            NameFull: Gritti G
      – PersonEntity:
          Name:
            NameFull: Pinter-Brown L
      – PersonEntity:
          Name:
            NameFull: Izutsu K
      – PersonEntity:
          Name:
            NameFull: Sidransky D
      – PersonEntity:
          Name:
            NameFull: Bentur OS
      – PersonEntity:
          Name:
            NameFull: Pro B
      – PersonEntity:
          Name:
            NameFull: Fox CP
      – PersonEntity:
          Name:
            NameFull: Brammer JE
      – PersonEntity:
          Name:
            NameFull: Horwitz SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 05
              Text: 2026 May 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1